Articles
Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial
Ballantyne CM, Banka P, Mendez G, et al.
Journal:
J Am Coll Cardiol
First published: March 6, 2023 DOI: 10.1016/j.jacc.2023.02.018
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.
ConfirmBallantyne CM, Banka P, Mendez G, et al.
J Am Coll Cardiol
First published: March 6, 2023 DOI: 10.1016/j.jacc.2023.02.018